NCT06234436View on ClinicalTrials.gov

Plasma Dilution and Infusion to Improve Cognition in Mild Cognitive Impairment (MCI)

EARLY_PHASE1Enrolling by invitationINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

December 7, 2023

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2025

Conditions
Alzheimer Disease
Interventions
BIOLOGICAL

Plasma exchenge

Plasma exchange will be conducted. The substitution fluid will be plasma from ha healthy donor.

Trial Locations (1)

0450

Oslo University Hospital, Oslo

All Listed Sponsors
collaborator

Impetus Grants (EIN: 87-1540960)

UNKNOWN

collaborator

The National Association for Public Health, Norway

OTHER_GOV

collaborator

Vestre Viken Hospital Trust

OTHER

lead

Oslo University Hospital

OTHER